Search

Your search keyword '"Cerrato García P"' showing total 3 results
Start Over Author "Cerrato García P"
3 results on '"Cerrato García P"'

1. Registro español de hemodinámica y cardiología intervencionista. XXXIII informe oficial de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (1990–2023)

Author

Bastante, Teresa, Arzamendi, Dabit, Martín-Moreiras, Javier, Cid Álvarez, Ana Belén, Carballo Garrido, Julio, Andraka, Leire, Gómez Jaume, Alfredo, Merino Otermin, Álvaro, Artáiz Urdaci, Miguel, Ruiz Salmerón, Rafael, Pérez de Prado, Armando, Cruz González, Ignacio, Calviño Santos, Ramon, Bayón, Jeremías, Trillo, Ramiro, Antonio Baz, José, Berenguer, Alberto, Casanova Sandoval, Juan M., Álvarez Antón, Salvador, Sabaté, Manel, Ruiz Nodar, Juan Miguel, Valero Picher, Ernesto, Amat Santos, Ignacio J., Ruiz Arroyo, José Ramón, Pinar Bermúdez, Eduardo, Íñigo-García, Luis Antonio, Arzamendi, Dabit, Jerez Valero, Miguel, Cerrato García, Pablo, Bosch Peligero, Eduard, Vaquerizo Montilla, Beatriz, Subinas Elorriaga, Asier, Sánchez Pérez, Ignacio, Jiménez Mazuecos, Francisco Javier, Tejada Ponce, David, Santos Martínez, Sandra, Moreu, José, Elízaga, Jaime, Cascón Pérez, José Domingo, García, Eulogio, Mainar, Vicente, Ávila González, María del Mar, Vergara, Rubén, Macaya, Carlos, Rasines Rodríguez, Alejandro, Fernández-Ortiz, Antonio, Ojeda Pineda, Soledad, Bethencourt González, Armando, Palazuelos, Jorge, López Palop, Ramón, Alegría Barrero, Eduardo, Camacho Freire, Santiago Jesús, Portero Pérez, María Pilar, Peña Perez, Gonzalo, Vázquez Álvarez, María Eugenia, Roura, Gerard, Agudelo, Víctor, Freixa, Xavier, Carrillo, Xavier, Mohandes, Mohsen, Muñoz Camacho, Juan F., Millán, Raúl, García del Blanco, Bruno, Sarnago, Fernando, Torres Bosco, Alfonso, Sáez, Roberto, Avanzas, Pablo, Pérez Vizcayno, María José, Caballero Borrego, Juan, Blanco Mata, Roberto, Merchán Herrera, Antonio, Luengo Mondéjar, Pablo, Lozano, Íñigo, Portales Fernández, Javier, Bosa Ojeda, Francisco, Martín Lorenzo, Pedro, Novo García, Enrique, Fernández Guerrero, Juan Carlos, González Caballero, Eva, Rivero, Fernando, Pomar, Francisco, Ruiz Quevedo, Valeriano, Morales Ponce, Francisco José, Ruiz García, Juan, Romero Vazquiánez, Manuela, Tellería, Miren, Baello Monge, Pascual, Botas Rodríguez, Javier, Franco Peláez, Juan Antonio, Unzue, Leire, Gómez Menchero, Antonio Enrique, Sánchez Recalde, Ángel, Jurado Román, Alfonso, Sainz Laso, Fermín, Fuertes Ferre, Georgina, Pimienta González, Raquel, Oteo Domínguez, Juan Francisco, Gutiérrez, Alejandro, Bullones Ramírez, Juan Antonio, Sánchez-Aquino González, Rosa, Frutos Garcia, Araceli, Fajardo Molina, Ricardo, Núñez Pernas, Daniel, Alonso Briales, Juan Horacio, Sánchez Gila, Joaquín, Sánchez Burguillos, Francisco J., Guisado Rasco, Agustín, Vizcaino Arellano, Manuela, Díez Gil, José Luis, de la Borbolla Fernández, Rafael García, Ramírez, Antonio, and Larman, Mariano

Abstract

Se presenta el informe de actividad del año 2023 de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (ACI-SEC).

Published
2024
Full Text
View/download PDF

2. Bioactive or Drug-Eluting Stents in 75 Years or Older Patients: The BIODES-75 Registry

Author

Córdoba-Soriano JG, Gutiérrez-Díez A, Del Blanco BG, Núñez J, Amat-Santos IJ, Oteo JF, Romaguera R, Gallardo-López A, Lozano Ruíz-Poveda F, Baello P, Aguar P, Jerez-Valero M, Jiménez-Díaz VA, Serra B, Cascon JD, Morales-Ponce FJ, Portero-Portaz JJ, Melehi El Assali D, Cerrato-García P, and Jiménez-Mazuecos J

Abstract

BACKGROUND: TiNO-coated BAS have demonstrated competitive outcomes compared to drug-eluting stents (DES). These devices allow short antiplatelet regimens and may be a good option for the growing elderly population undergoing percutaneous coronary intervention (PCI). METHODS: Multicenter observational trial in routine clinical practice. A propensity-score matched analysis compared a prospective cohort of patients = 75 years undergoing PCI with BAS, with a contemporary and retrospective cohort treated with last-generation DES. The co-primary endpoints of the study were the Target-Lesion-Failure (Cardiac death, non-fatal myocardial infarction, or target lesion revascularization) and Major Adverse Cardiovascular Events (total death, non-fatal myocardial infarction, stroke, or new revascularization) at 1 year. RESULTS: Whole population included 1000 patients, and 326 patients in each group were matched for analysis. No differences in primary endpoints were found: TLF 10.4% vs. 11% (HR 0.96 (Confidence Interval 95%, 0.36-1.7; p = 0.87)) and MACE 16.3% vs. 17.2% (HR 0.98 (Confidence Interval 95%; 0.3-1.5, p = 0.93)). Patients treated with BAS received shorter antiplatelets regimens (dual antiplatelet therapy at 1 year, 25.7% vs. 70.6%, p = 0.0001), and they presented lower incidence of bleeding (3.7% vs. 11.7%, HR 0.3 (IC 95% 0.16-0.6, p = 0.001)). CONCLUSION: In this real-life registry of patients = 75 years, BAS were similar to the latest-generation DES in terms of efficacy and reduced the duration of the antithrombotic therapy, lowering bleeding events.

Published
2022

3. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023).

Author

Bastante T, Arzamendi D, Martín-Moreiras J, Cid Álvarez AB, Carballo Garrido J, Andraka L, Gómez Jaume A, Merino Otermin Á, Artáiz Urdaci M, Ruiz Salmerón R, Pérez de Prado A, Cruz González I, Calviño Santos R, Bayón J, Trillo R, Antonio Baz J, Berenguer A, Casanova Sandoval JM, Álvarez Antón S, Sabaté M, Ruiz Nodar JM, Valero Picher E, Amat Santos IJ, Ruiz Arroyo JR, Pinar Bermúdez E, Íñigo-García LA, Arzamendi D, Jerez Valero M, Cerrato García P, Bosch Peligero E, Vaquerizo Montilla B, Subinas Elorriaga A, Sánchez Pérez I, Jiménez Mazuecos FJ, Tejada Ponce D, Santos Martínez S, Moreu J, Elízaga J, Cascón Pérez JD, García E, Mainar V, Ávila González MDM, Vergara R, Macaya C, Rasines Rodríguez A, Fernández-Ortiz A, Ojeda Pineda S, Bethencourt González A, Palazuelos J, López Palop R, Alegría Barrero E, Camacho Freire SJ, Portero Pérez MP, Peña Perez G, Vázquez Álvarez ME, Roura G, Agudelo V, Freixa X, Carrillo X, Mohandes M, Muñoz Camacho JF, Millán R, García Del Blanco B, Sarnago F, Torres Bosco A, Sáez R, Avanzas P, Pérez Vizcayno MJ, Caballero Borrego J, Blanco Mata R, Merchán Herrera A, Luengo Mondéjar P, Lozano Í, Portales Fernández J, Bosa Ojeda F, Martín Lorenzo P, Novo García E, Fernández Guerrero JC, González Caballero E, Rivero F, Pomar F, Ruiz Quevedo V, Morales Ponce FJ, Ruiz García J, Romero Vazquiánez M, Tellería M, Baello Monge P, Botas Rodríguez J, Franco Peláez JA, Unzue L, Gómez Menchero AE, Sánchez Recalde Á, Jurado Román A, Sainz Laso F, Fuertes Ferre G, Pimienta González R, Oteo Domínguez JF, Gutiérrez A, Bullones Ramírez JA, Sánchez-Aquino González R, Frutos Garcia A, Fajardo Molina R, Núñez Pernas D, Alonso Briales JH, Sánchez Gila J, Sánchez Burguillos FJ, Guisado Rasco A, Vizcaino Arellano M, Díez Gil JL, de la Borbolla Fernández RG, Ramírez A, and Larman M

Subjects
Spain, Humans, Registries, Cardiac Catheterization methods, Cardiac Catheterization statistics & numerical data, Societies, Medical, Percutaneous Coronary Intervention methods, Percutaneous Coronary Intervention statistics & numerical data, Cardiology
Abstract

Introduction and Objectives: This article presents the 2023 activity report of the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC)., Methods: All interventional cardiology laboratories in Spain were invited to participate in an online survey. Data analysis was carried out by an external company and subsequently reviewed and presented by the members of the ACI-SEC board., Results: A total of 119 hospitals participated. The number of diagnostic studies decreased by 1.8%, while the number of percutaneous coronary interventions (PCI) showed a slight increase. There was a reduction in the number of stents used and an increase in the use of drug-coated balloons. The use of intracoronary diagnostic techniques remained stable. For the first time, data on PCI guided by intracoronary imaging was reported, showing a 10% usage rate in Spain. Techniques for plaque modification continued to grow. Primary PCI increased, becoming the predominant treatment for myocardial infarction (97%). Noncoronary structural procedures continued their upward trend. Notably, the number of left atrial appendage closures, patent foramen ovale closures, and tricuspid valve interventions grew in 2023. There was also a significant increase in interventions for acute pulmonary embolism., Conclusions: The 2023 Spanish cardiac catheterization and coronary intervention registry indicates a stabilization in coronary interventions, together with an increase in complexity. There was consistent growth in procedures for both valvular and nonvalvular structural heart diseases., (Copyright © 2024 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results